XML 19 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:    
Net income including noncontrolling interests $ 111,293 $ 110,534
Adjustments to reconcile net income to net cash used in operating activities:    
Depreciation and amortization 25,875 22,590
Share-based compensation expenses related to equity classified awards 5,645 8,129
Amortization of program rights 187,073 192,852
Amortization of deferred carriage fees 5,100 8,657
Unrealized foreign currency transaction loss 1,626 1,073
Amortization of deferred financing costs and discounts on indebtedness 1,938 1,898
Bad debt expense 363 820
Deferred income taxes (6,269) 21,430
Gain on investments 0 (4,293)
Other, net (260) (2,447)
Changes in assets and liabilities:    
Accounts receivable, trade 15,893 37,510
Prepaid expenses and other assets 78,442 (1,910)
Program rights and obligations, net (370,304) (340,300)
Income taxes payable 1,084 8,039
Deferred revenue (64,702) 6,715
Deferred carriage fees, net (2,410) (9,934)
Accounts payable, accrued liabilities and other liabilities (122,906) (84,918)
Net cash used in operating activities (132,519) (23,555)
Cash flows from investing activities:    
Capital expenditures (11,498) (11,528)
Return of capital from investees 0 1,771
Proceeds from sale of investments 4,493 0
Net cash used in investing activities (7,005) (9,757)
Cash flows from financing activities:    
Principal payments on long-term debt (8,438) (8,438)
Deemed repurchases of restricted stock units (6,012) (20,292)
Principal payments on finance lease obligations (1,015) (716)
Distributions to noncontrolling interests (11,502) (1,565)
Purchase of noncontrolling interests (1,343) 0
Net cash used in financing activities (28,310) (31,011)
Net decrease in cash and cash equivalents from operations (167,834) (64,323)
Effect of exchange rate changes on cash and cash equivalents 1,764 (6,272)
Cash and cash equivalents at beginning of period 930,002 892,221
Cash and cash equivalents at end of period $ 763,932 $ 821,626